1
Apr

Kimmel Cancer Center Hosts Program to Help Patients and Families Learn More About Living with Cancer April 2

The Kimmel Cancer Center at Jefferson in Philadelphia is holding a program on Wednesday, April 2, 2008 for patients, families and caregivers whose lives have been touched by cancer. “Life After A Cancer Diagnosis” will feature speakers addressing topics ranging from exercise and cancer fatigue to caregiver issues to questions about fertility and sexuality after …

31
Mar

Kimmel Cancer Center Scientist Named Editor-in-Chief of Prestigious Pathology Journal

Renowned cell biologist Michael P. Lisanti, M.D., Ph.D., the Margaret Q. Landenberger Professor in Breast Cancer Research at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson in Philadelphia, has been named Editor-in-Chief of The American Journal of Pathology (AJP). His term begins in July. Dr. Lisanti, who serves as …

17
Mar

Jefferson Establishes New Center to Study Stem Cells and Regenerative Medicine

Thomas Jefferson University has established a new center to study the biology, behavior and the potential medical uses of adult stem cells in a variety of diseases, including neurological disease and cancer. The Jefferson Stem Cell Biology and Regenerative Medicine Center will be directed by renowned cell biologist Michael P. Lisanti, M.D., Ph.D., professor of …

29
Feb

Blocking Growth Protein Kills Prostate Cancer Cells, Inhibits Tumor Growth, Jefferson Scientists Find

Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer’s growth. The work proves that the protein, Stat5, is both vital to prostate cancer cell maintenance and …

27
Feb

New Jefferson Trial to Test Radiation-Emitting Beads Against Advanced Liver Cancer

Liver cancer specialists at Jefferson’s Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver’s main artery while also blocking the blood supply feeding the cancer’s growth. The technique, called radioembolization, has been …

27
Feb

Kimmel Cancer Center Faculty Elected as Secretary of the Association of Cancer Executives (ACE)

Joy Soleiman, MPA, Clinical Administrator of the Kimmel Cancer Center, was elected to a two year term as Secretary of the Association of Cancer Executives (ACE). It was officially announced at their annual meeting in San Francisco February 16 to 19, 2008. ACE is a leading cancer administrator networking organization for over a decade with …

27
Feb

Jefferson Scientists Uncover Role of Cancer Stem Cell Marker: Controlling Gene Expression Patterns

Scientists at Jefferson’s Kimmel Cancer Center in Philadelphia have made an extraordinary advance in the understanding of the function of a gene previously shown to be part of an 11-gene “signature” that can predict which tumors will be aggressive and likely to spread. The gene, USP22, encodes an enzyme that appears to be crucial for …

21
Jan

Jefferson Scientists Find Protein Helps Pancreatic Cancer Cells Hide from Immune System, Allowing Spread

A protein that helps prevent a woman’s body from rejecting a fetus may also play an important role in enabling pancreatic cancer cells to evade detection by the immune system, allowing them to spread in the body. Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia found that the metastatic cancer cells in the lymph nodes …

3
Jan

Jefferson Scientists Find Cell Growth Protein Potential Drug Target for Treatment-Resistant Prostate Cancer

Scientists at Jefferson’s Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. If the findings hold up, the protein, called Stat5, may be a specific drug target against an extremely …

3
Jan

“C” to Believe: Jefferson Scientists Studying the Effects of High Dose Vitamin C on Non-Hodgkin Lymphoma Patients

Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether …

Page 1 of 24